Brief: Lyell Immunopharma Inc - To Close West Hills Manufacturing Facility - SEC Filing
01/04/2025 22:05
April 1 (Reuters) - Lyell Immunopharma Inc LYEL.O: LYELL IMMUNOPHARMA INC - TO CLOSE WEST HILLS MANUFACTURING FACILITY - SEC FILING LYELL IMMUNOPHARMA INC - TO REDUCE WORKFORCE BY 73 EMPLOYEES IN WEST HILLS - SEC FILING LYELL IMMUNOPHARMA INC - EXPECTS $3M-$4M EXPENSES FROM WORKFORCE REDUCTION - SEC FILING LYELL IMMUNOPHARMA INC - LYFE MANUFACTURING CENTER PRODUCING IMPT-314 FOR PHASE 1/2 TRIAL - SEC FILING LYELL IMMUNOPHARMA INC - LYFE MANUFACTURING CENTER EXPECTED TO MEET DRUG SUPPLY NEEDS - SEC FILING LYELL IMMUNOPHARMA INC: REITERATES ITS FINANCIAL GUIDANCE Source text: [ID:n0001193125-25-070521] Further company coverage: LYEL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma